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Abstract
Background: Cerebral venous sinus thrombosis is an infrequent disease with a variety of causes.
Pregnancy, puerperium, contraceptive pills and intracranial infections are the most common causes.
The patient may present with headache, focal neurological deficits and seizures.
The clinical outcome is highly variable and treatment with heparin is advised.
Case presentation: The patient is a 22 year old male who presented with headache, repeated
vomiting and papilledema.
He was a bodybuilder doing exercise since 5 years ago, who had used nandrolone decaonoate 25
milligrams intramuscularly during the previous 5 months. Brain MRI and MRV showed superior
sagital and transverse sinus thrombosis and extensive investigations did not reveal any known
cause.
Conclusions: We suggested that androgen was the predisposing factor in our patient. Androgens
may increase coagulation factors or platelet activity and cause arterial or venous thrombosis.
As athletes may hide using androgens it should be considered as a predisposing factor for 
thrombotic events in such patients.
Background
Cerebral venous sinus thrombosis (CVST) is a disease
with a wide spectrum of non specific clinical signs and
symptoms, including headache, focal neurological defi-
cits, seizures and coma.
The clinical outcome is highly variable; patients may
recover completely or may develop severe and lasting neu-
rological deficits [1].
There are many causes for this disease but the most com-
mon predisposing factors are pregnancy, puerperium,
contraceptive pills, coagulopathies and intracranial infec-
tions [2].
There are few reports of patients with CVST after androgen
therapy. We present a young bodybuilder man who devel-
oped CVST with abusing androgens for increasing muscle
mass.
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Case presentation
In May 2004 a 22 year old male was admitted to our
department with chief complaints of headache and
vomiting.
The patient was well till 10 days prior to admission that
developed progressive, intense bitemporal headache exac-
erbated with bending.
The patient also had history of malaise, nausea and sev-
eral episodes of vomiting from 3 days before admission.
The only objective finding on physical examination was
bilateral papilledema. The patient was a body builder
doing exercise from 5 years ago who had used nandrolone
decaonoate 25 mg once or twice a week during the last 5
months. He had injected 20 ampoules in this period.
Brain computed tomography without contrast was done
for the patient which showed cord sign, emergency MR
imaging including T1 – T2, weighted and MRV showed
prominent superior sagital and transverse sinus thrombo-
sis. The C.S.F opening pressure was 480 mm/H2o without
any other abnormality. Heparin 80 IU/kg started as load-
ing dose then continued 1000 IU/ hr for 10 days. On the
5th  day of treatment headache resolved and warfarin
added to heparin.
Laboratory tests including antithrombin III activity, pro-
tein C, S factor V leiden, Plasma hemocystein and anticar-
diolipin were all within normal limits.
The patient was discharged in a good condition and was
maintained on 6 months warfarin protcol.
Discussion
There are few reports of CVST following androgen therapy
[3], but there is just one reported case of CVST in andro-
gen using young body builder [4]. The anabolic activity of
testosterone and its derivatives is primarily manifested in
its myotrophic actions which result in greater muscle mass
and strength.
This has led to widespread use of androgenic anabolic
steroids by athletes at all levels. Nandrolone decaonoate is
a synthetic anabolic steroid. In focus on homeostasis sys-
tem the most important factors under testosterone regula-
tion are fibrinogen, Plasminogen activator inhibitor-1
(PAI – 1) and platelet aggregability.
The current data indicate that testosterone lowers fibrino-
gen and PAI – 1, however these anticoagulatory and profi-
brinolytic may be opposed by proaggregatory effects on
platelets because high dosages of androgens were found
to decrease cycloxygenase activity and thereby increase
platelet functions [5].
Proaggregatory effect of testosterone and other synthetic
androgens become more reliable theory for CVST, accord-
ing to recent publication [6].
Conclusions
This case report presents a patient with CVST following
exogenous androgen usage with a mechanism which is
not completely understood, but it may be related to plate-
let activation or an increase in coagulation factors. As
androgen use may be frequent and hidden in athletes, it
may be an underestimated cause of cerebral venous
thrombosis in young adults and careful history should be
taken in these groups of patients.
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T1 weighted horizontal nonGd Images show transverse sinus thrombosis Figure 1
T1 weighted horizontal nonGd Images show transverse sinus thrombosis.BMC Neurology 2004, 4:22 http://www.biomedcentral.com/1471-2377/4/22
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T1 weighted sagital Images with Gd show thrombosis in sagital sinus Figure 2
T1 weighted sagital Images with Gd show thrombosis in sagital sinus.BMC Neurology 2004, 4:22 http://www.biomedcentral.com/1471-2377/4/22
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2D MR venogram shows sagital sinus thrombosis Figure 3
2D MR venogram shows sagital sinus thrombosis.Publish with BioMed Central    and   every 
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